Literature DB >> 32544697

COVID-19 experience reports: an emerging trend in scholarly communication.

A K Kaliya-Perumal1, J Kharlukhi2, U F Omar3.   

Abstract

Entities:  

Year:  2020        PMID: 32544697      PMCID: PMC7266761          DOI: 10.1016/j.puhe.2020.05.056

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


× No keyword cloud information.
The current coronavirus disease 2019 (COVID-19) pandemic has unprecedentedly affected most parts of the world and has once again proved that humans are still vulnerable. However, unlike other pandemics that the world has encountered, this time we are at an advantage as almost everyone is aware of the entire situation as it evolves. This can be attributed to the established and swift communication methods that are in place for sharing information. These communication methods need to be appropriately used as interactions between countries that are in different phases of the pandemic are of extreme importance, and vital information needs to be responsibly shared with people via the various available platforms (print, broadcast and social). While this is happening on one end, the academic community is seeing an influx of COVID-19–related information as scholarly communications (journal articles) of different types and most publishers have made these articles open access. Thus, evidence from experts to inform practice and influence policymaking is available at ease. One such type of evidence that has become increasingly popular is regional experience reports. These are qualitative observations of successful stories, difficulties or lessons learnt by a particular country, community, institution or a group. For example, experience reports from healthcare professionals focus on the way they have adapted to the pandemic while still providing routine care operations. , Today, because the disease has spread across the world, articles of this type, either as reviews, short communications or correspondences, are coming in from various regions and backgrounds. On doing a PubMed search on May 13, 2020, using the search strategy ‘COVID[All Fields] OR (“coronavirus”[MeSH Terms] OR “coronavirus”[All Fields]) AND experience[ti]’, we found 262 articles, among which 105 were experience reports from various backgrounds. A majority of these reports (36.2%) were from Asia, with China being the largest contributor (Table 1 ).4, 5, 6 Europe, predominantly Italy, and North America, predominantly the USA, had the second and third highest number of reports, respectively. ,
Table 1

Number of experience reports from around the world.

RegionNo. of reportsOverall percentageMajority
Asia3836.2China (57.9%)
Europe3331.4Italy (81.8%)
North America1918.1USA (94.7%)
Middle East65.7
Australia10.95
Multicentre87.6
Total105
Number of experience reports from around the world. These reports play a unique role in informing practice at various levels to effectively improvise, adapt and overcome the situation. They highlight what key measures countries, communities, institutions or groups can take and what effect it will have on themselves or the population. Referring to such reports can save the need for devising or testing new strategies and prevents from adopting failed ones, while reported successful strategies can be followed wherever possible. However, considering the differences between backgrounds, it may be difficult for one to follow the same strategy taken by another who has managed the pandemic successfully. In such cases, experience reports stand out as evidence that points out areas that need to be strengthened based on which help can be sought. In addition to being reviewed and reliable sources of evidence on the measures taken during the pandemic, these experience reports could influence policymaking after the pandemic is over, be it in the country of origin or elsewhere. It may become necessary for governments and institutions to look back at themselves or at models and take every action possible to not let another pandemic rattle up the world as COVID-19 has done so far. For this reason, everyone's experience, irrespective of success or failure, needs to be told. More experiences from different parts of the world should be available for discussion and an opportunity for learning from each other should be created.
  8 in total

Review 1.  Understanding the Singapore COVID-19 Experience: Implications for Hospital Medicine.

Authors:  Arpana R Vidyarthi; Natasha Bagdasarian; Armond M Esmaili; Sophia Archuleta; Bradley Monash; Niraj L Sehgal; Adrienne Green; Aymeric Lim
Journal:  J Hosp Med       Date:  2020-04-16       Impact factor: 2.960

2.  How Is COVID-19 Affecting South Korea? What Is Our Current Strategy?

Authors:  Minyoung Her
Journal:  Disaster Med Public Health Prep       Date:  2020-04-03       Impact factor: 1.385

3.  COVID-19 experience in Bergamo, Italy.

Authors:  Michele Senni
Journal:  Eur Heart J       Date:  2020-05-14       Impact factor: 29.983

4.  Coronavirus Disease 2019 in Children - United States, February 12-April 2, 2020.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-10       Impact factor: 17.586

5.  New Measures for the Coronavirus Disease 2019 Response: A Lesson From the Wenzhou Experience.

Authors:  Linhui Ruan; Min Wen; Qingrun Zeng; Chengshui Chen; Shengwei Huang; Su Yang; Jianjing Yang; Jingqiang Wang; Yuhuan Hu; Saidan Ding; Ying Zhang; Hongxia Zhang; Yuanjing Feng; Kunlin Jin; Qichuan Zhuge
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

6.  COVID-19: learning from experience.

Authors: 
Journal:  Lancet       Date:  2020-03-28       Impact factor: 79.321

7.  COVID-19: Initial experience of hand surgeons in Northern Italy.

Authors:  F Facchin; F Messana; R Sonda; D Faccio; C Tiengo; F Bassetto
Journal:  Hand Surg Rehabil       Date:  2020-05-04       Impact factor: 0.969

8.  Response to the COVID-19 Epidemic: The Chinese Experience and Implications for Other Countries.

Authors:  Wei Liu; Xiao-Guang Yue; Paul B Tchounwou
Journal:  Int J Environ Res Public Health       Date:  2020-03-30       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.